About Mokshit
Health Economist with an MSc in Health Economics based in Hamburg, Germany. I help healthcare companies navigate complex EU/UK market access and reimbursement landscapes. With experience in both the pharmaceuticals and medical device markets, I specialize in literature screening, reimbursement landscape mapping, economic modelling, and preparing value dossiers. Whether you need reimbursement codes mapping, analysis of global pricing data and market trends, or systematic reviews for evidence development, I translate clinical data into compelling economic value.
Areas of Expertise:
✅ Market Access & HTA Strategy
Value dossier (EUnetHTA JCA compliant submissions)
HTA and reimbursement applications across EU4, Nordics, and the UK
Reimbursement landscape mapping and pricing analysis
Reimbursement code mapping and analysis
Reimbursement justification dossiers and code-gap risk assessment
✅ Health Economics & Modeling
Cost effectiveness (ICER), cost utility, and cost savings analysis
Individual simulation and population cohort economic models
Decision trees and simple Markov modeling
✅ Evidence Generation & Real-World Evidence (RWE)
Systematic literature reviews (SLR) and meta analysis
Evidence generation strategies tailored to payer, physician, and patient messaging
Real world evidence design and analysis
Medical/scientific writing for publications
✅ Data Analysis Proficiency
R (RStudio and ggplot2)
IBM SPSS
Excel with VBA
With expertise in HEOR and market access, I'm ready to support your project from evidence to submission.
Thanks!
Mokshit Bhagat
(Health Economist, MSc)
English
Native or bilingual
German
Conversational
Remote only
Primarily works remotely
Experience
- FreelancerHealth EconomistMarch 2025 - Today (1 year and 5 months)Hamburg, Germany• • In collaboration with Coreva Scientific: Led mapping of reimbursement codes for medical devices, applying HTA processes and strategic planning to identify gaps where generic descriptions enable low cost competitors; developed a prioritization framework based on price ratio and clinical risk, and created a differentiation matrix and reimbursement dossier that secured more specific, value based reimbursement.• • Produced HEOR driven real world evidence (RWE) on the societal impact of early intensified treatment for T2DM and CVD in Mexico by designing individual simulation and population cohort economic models; performed complex problem solving and data interpretation to quantify health implications including cost savings, cost effectiveness, and avoided productivity loss over a 5-10 year horizon using the Human Capital Approach.• • Secured key correlational insights on DZNE clinical dataset using SPSS (v30) to compare patient reported health utility (EQ-5D index) against clinical severity (SARA score) in Friedreich's Ataxia (FA). Demonstrated a strong correlation between clinical severity and health utility, informing evidence based medical standards and the need for multidimensional PROs in clinical assessments.• • Supported HTA activities and reimbursement applications through economic modeling and data analysis, translating complex medical data into strategic insights for pharmaceutical decision-making in cross-functional settings.
- Boehringer Ingelheim,Global HEOR InternAugust 2023 - July 2024 (11 months)Ingelheim am Rhein, RP, Germany• • Led strategic planning to identify decision drivers for pricing, reimbursement, and HTA processes across EU 27, Switzerland, and the UK, enabling data-driven decision-making that informed market-access strategies.• • Developed a comprehensive AMNOG value dossier for LCNEC-L in the TA oncology, ensuring compliance with EUnetHTA JCA dossier submission guidelines through effective team collaboration.• • Conducted extensive research, systematic reviews, and economic analysis, providing valuable insights and real-world evidence (RWE) to inform decision-making in HEOR.• • Executed an effective and proactive Clinical Outcome Assessment (COA) strategy to improve the quality and quantity of COA data in Boehringer's Clinical Trials.• • Managed the project to implement structured systems for patient-reported outcomes (PROs) measures, coordinating with cross-functional stakeholders to optimize verification and tracking for the COA library, thereby enhancing efficiency and accuracy.• • Interviewed HEOR managers to validate Patient Global Impressions (PGIs) and optimize patient data analysis accuracy.
- MedBound,Medical Scientific WriterApril 2022 - June 2022 (2 months)Chicago, IL, USA• • Translated complex health science topics into clear communications: delivered webinars and presentations on topics such as Toxic Shock Syndrome and the RAND Health Insurance Experiment.• • Produced evidence-based articles and conducted desk research to support the company's scientific knowledge base and external communications.
Recommendations
Be the first to recommend Mokshit
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- Master of Science (MSc)Hochschule Fresenius2024Master of Science (MSc)
- IMTA Training (Health Economics and Outcome Research (HEOR))Erasmus University2024IMTA Training (Health Economics and Outcome Research (HEOR))
Certifications
- R Programming A-Z™: RFor Data Science With Real Exercises!Udemy2026
Categories
- Other